Share this via
Despite policy interventions from both Trump and Biden administrations, US manufacturing is showing signs of stagnation, marked by job losses and tepid production. Factors such as inflationary pressures, interest rate hikes, and tariff uncertainties contribute to the slowdown. With policy flip-flops and weak demand, factories are holding back on hiring and investment, awaiting a clearer direction.
As a part of agreement, Incyte has granted to Sun a limited, non-exclusive license to U.S. Patent and certainother related patents with respect to oral deuruxolitinib for certain agreed-upon non-hematology-oncology indications including alopecia areata, in the U.S.
Get over your FOMO of knowing what's happening. Never miss what matters to you!
